4-nitroquinoline-1-oxide has been researched along with Severe Combined Immunodeficiency in 1 studies
4-nitroquinoline N-oxide : A quinoline N-oxide carrying a nitro substituent at position 4.
Severe Combined Immunodeficiency: Group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. It is inherited as an X-linked or autosomal recessive defect. Mutations occurring in many different genes cause human Severe Combined Immunodeficiency (SCID).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thomas, GR | 1 |
| Chen, Z | 1 |
| Oechsli, MN | 1 |
| Hendler, FJ | 1 |
| Van Waes, C | 1 |
1 other study available for 4-nitroquinoline-1-oxide and Severe Combined Immunodeficiency
| Article | Year |
|---|---|
Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma.
Topics: 4-Nitroquinoline-1-oxide; Animals; Animals, Congenic; B7-1 Antigen; Biomarkers, Tumor; Carcinoma, Sq | 1999 |